Peptide research
Melanotan II (MT-II) has a history of enforcement and safety scrutiny. Pharmacies and clinics should expect restrictive or unclear posture unless a clear federal chain step and state rule support compounding.
Common names: MT-II, Melanotan 2
PeptSense tracks Melanotan II across federal 503A Bulks List chain steps, PCAC advisory context, and state board positions. Status is never inferred from forums or marketing sites — only published citations with effective dates.
No published federal 503A event for Melanotan II yet. Curation publishes chain-step citations as they are reviewed.
Get federal + state lanes, chain steps, printable answer cards, and compliance documents for the states you license in.